Monika Stoll


Prof. Monika Stoll graduated from University of Giessen, Germany, where she received her Diploma in Biology in 1991, before finishing a PhD in Pharmacology in 1995 at University of Heidelberg, Germany. She then assumed a post-doctoral fellowship at the Medical College of Wisconsin, USA, where she discovered her interest in complex genetics and genomics. In 2003, she became Professor and Director of the Division Genetic Epidemiology at the Leibniz-Institute for Arteriosclerosis Research, and starting 2014, at the Institute of Human Genetics of the University of Muenster, Germany. In October 2013 she assumed a part-time position as Visiting Professor in Cardiovascular Genetics at Maastricht University. In 2015, she was appointed as Extraordinary Professor of Genetic Epidemiology and Statistical Genetics. In October 2016, she was appointed as Vice-Rector for Research of the University of Muenster.

Prof. Stoll is engaged in research in complex genetics and genetic epidemiology particularly relating to cardiovascular diseases and inflammation. Current research projects address the genetic and genomic basis of arrhythmogenic diseases and heart failure. She is involved in a number of large research networks, such as the EU-funded Horizon2020 consortium CATCH-ME, CVON RACE-V, CVON-PREDICT2 and the ITN TRAIN-HEART, and is responsible for all aspects of next generation sequencing approaches and the analysis thereof in the context of the pathogenesis of cardiovascular diseases. In addition, her group is running a core facility for genomics which supports high-density arrays and next generation sequencing applications and a (bio)informatics infrastructure for management and analysis of such large data sets.

Department of Biochemistry
Department of Genetic Epidemiology and Statistical Genetics
Universiteitssingel 60, 6229 ER Maastricht
PO Box 616, 6200 MD Maastricht

  • 2022
    • Young, W. J., Lahrouchi, N., Isaacs, A., Duong, T., Foco, L., Ahmed, F., Brody, J. A., Salman, R., Noordam, R., Benjamins, J-W., Haessler, J., Lyytikäinen, L-P., Repetto, L., Concas, M. P., van den Berg, M. E., Weiss, S., Baldassari, A. R., Bartz, T. M., Cook, J. P., ... Munroe, P. B. (2022). Genetic analyses of the electrocardiographic QT interval and its components identify additional loci and pathways. Nature Communications, 13(1), [5144].
    • Ottaviani, L., Juni, R. P., de Abreu, R. C., Sansonetti, M., Sampaio-Pinto, V., Halkein, J., Hegenbarth, J. C., Ring, N., Knoops, K., Kocken, J. M. M., Jesus, C. D., Ernault, A. C., El Azzouzi, H., Rühle, F., Olieslagers, S., Fernandes, H., Ferreira, L., Braga, L., Stoll, M., ... da Costa Martins, P. A. (2022). Intercellular transfer of miR-200c-3p impairs the angiogenic capacity of cardiac endothelial cells. Molecular Therapy, 30(6), 2257-2273.
    • Christ, A., Goossens, P. G., Wijnands, E., Jin, H., Legein, B., Oth, T., Isaacs, A., Stoll, M., Vanderlocht, J., Lutgens, E., Daemen, M. J. A. P., Zenke, M., & Biessen, E. A. L. (2022). Low Density Lipoprotein Exposure of Plasmacytoid Dendritic Cells Blunts Toll-like Receptor 7/9 Signaling via NUR77. Biomedicines, 10(5), [1152].
    • Jauch-Speer, S-L., Herrera-Rivero, M., Ludwig, N., Véras De Carvalho, B. C., Martens, L., Wolf, J., Imam Chasan, A., Witten, A., Markus, B., Schieffer, B., Vogl, T., Rossaint, J., Stoll, M., Roth, J., & Fehler, O. (2022). C/EBPδ-induced epigenetic changes control the dynamic gene transcription of S100a8 and S100a9. Elife, 11, [75594].
    • Limperger, V., Torge, A., Kiesau, B., Langer, F., Kenet, G., Mesters, R., Juhl, D., Stoll, M., Shneyder, M., Kowalski, D., Bajorat, T., Rocke, A., Kuta, P., Lasarow, L., Spengler, D., Junker, R., & Nowak-Göttl, U. (2022). Validation of a predictive model for identifying an increased risk for recurrence in adolescents and young adults with a first provoked thromboembolism. Blood Cells Molecules and Diseases, 94, [102651].
    • Witten, A., Martens, L., Schäfer, A-C., Troidl, C., Pankuweit, S., Vlacil, A-K., Oberoi, R., Schieffer, B., Grote, K., Stoll, M., & Markus, B. (2022). Monocyte subpopulation profiling indicates CDK6-derived cell differentiation and identifies subpopulation-specific miRNA expression sets in acute and stable coronary artery disease. Scientific Reports, 12(1), [5589].
    • Herrera-Rivero, M., Gandhi, S., Witten, A., Ghalawinji, A., Schotten, U., & Stoll, M. (2022). Cardiac chamber-specific genetic alterations suggest candidate genes and pathways implicating the left ventricle in the pathogenesis of atrial fibrillation. Genomics, 114(2), [110320].
    • Simons, C. C. J. M., Offermans, N. S. M., Stoll, M., van den Brandt, P. A., & Weijenberg, M. P. (2022). Empirical Investigation of Genomic Clusters Associated with Height and the Risk of Postmenopausal Breast and Colorectal Cancer in the Netherlands Cohort Study. American Journal of Epidemiology, 191(3), 413-429.
    • Grabowski, K., Herlan, L., Witten, A., Qadri, F., Eisenreich, A., Lindner, D., Schadlich, M., Schulz, A., Subrova, J., Mhatre, K. N., Primessnig, U., Plehm, R., van Linthout, S., Escher, F., Bader, M., Stoll, M., Westermann, D., Heinzel, F. R., & Kreutz, R. (2022). Cpxm2 as a novel candidate for cardiac hypertrophy and failure in hypertension. Hypertension Research, 45(2), 292-307.
    • Simons, C. C. J. M., Schouten, L. J., Godschalk, R. W. L., Van Schooten, F. J., Stoll, M., Van Steen, K., van den Brandt, P. A., & Weijenberg, M. P. (2022). Polymorphisms in the mTOR-PI3K-Akt pathway, energy balance-related exposures and colorectal cancer risk in the Netherlands Cohort Study. Biodata Mining, 15(1), [2].